5 recruiting, 3 not yet recruiting, 3 unknown, 2 completed. 4 Not applicable, 2 Phase 2, 2 Phase 4, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 4 | Recruiting 2, Completed 1, Not yet recruiting 1 |
| Phase 2 | 2 | Not yet recruiting 1, Unknown 1 |
| Phase 4 | 2 | Not yet recruiting 1, Recruiting 1 |
| Phase 1 | 1 | Completed 1 |
| Phase 3 | 1 | Recruiting 1 |
Follow Gout Arthritis: new trials by email Literature Review of Gout Arthritis trials Research Report on Gout Arthritis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of SSGJ-613 in Gout Participants Initiating Urate-Lowering Treatment SSGJ-613 100 mg Q12W, SSGJ-613 200 mg Q12W, SSGJ-613 100 mg Q4W - Gout Arthritis | Phase 2 | Not yet recruiting | Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. | 200 | 2026-08-02 | 2026-07-20 |
| Digital Care for Holistic Health in Older Adults With Diabetes and Multimorbidity Digital Care Community Common Good Program, Usual Care - Type2Diabetes, Hypertension | Not applicable | Recruiting | Chang Gung University of Science and Technology | 169 | 2026-05-12 | 2026-08-21 |
| HLA-B*58:01-Guided Therapy for Gout: Effectiveness, Safety, and Cost-Effectiveness HLA-B*58:01 Genotyping, Allopurinol Tablet, Febuxostat - Gout Initiating Urate-loweringUrate-lowering Therapy, Gout Arthritis | Phase 4 | Not yet recruiting | Haiphong University of Medicine and Pharmacy | 228 | 2026-01-20 | 2026-01-27 |
| An Exploratory Clinical Study on the Protective Effect of Cycling on the Ankle Joint in Gout Urate-lowering therapy (ULT), Jogging, Cycling - Gout Arthritis, Cycling | Not applicable | Not yet recruiting | Zhu Xiaoxia | 90 | 2026-01-01 | 2025-12-31 |
| Purified Cortrophin® Gel Efficacy and Safety Study of 2 Dose Levels in Patients With Acute Gout Flares Purified Cortophin Gel, 40 U, Purified Cortophin Gel 80 U - Gout Arthritis, Gout Flare | Phase 4 | Recruiting | Massachusetts General Hospital | 150 | 2025-12-20 | 2026-01-20 |
| Nurse-Led Telehealth for Gout Nurse-Led Self-Management Support, GP-follow up - Health Literacy, Gout Arthritis | Not applicable | Recruiting | University of Aarhus | 200 | 2025-10-01 | 2025-09-18 |
| Clinical Assessment for Rheumatologic Disease - Research and Advancement in Safety and Efficacy Ex Vivo Assay - Rheumatic Diseases, Rheumatoid Arthritis (RA) | Recruiting | University of Bonn | 120 | 2025-04-01 | 2025-09-02 | |
| Efficacy Anda Safety of Etoricoxib With Betamethasone for the Treatment of Acute Gout Arthritis Etoricoxib + Betamethasone fixed dose, Etoricoxib fixed dose - Gout Arthritis, Gout Attack | Phase 3 | Recruiting | Laboratorios Silanes S.A. de C.V. | 72 | 2025-01-27 | 2025-04-03 |
| A Study of SSGJ-613 in Gout Subjects Initiating Urate-Lowering Treatment. Recombinant Anti-IL-1β Humanized Monoclonal Antibody Injection 100 mg, Recombinant Anti-IL-1β Humanized Monoclonal Antibody Injection 200 mg, Colchicine 0.5 mg - Gout Arthritis | Phase 2 | Unknown | Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. | 157 | 2024-03-30 | 2024-08-05 |
| A Study to Investigate the Pharmacokinetic/Pharmacodynamic Characteristics of IBI128(A New Xanthine Oxidase Inhibitor) dose-5 group, dose-1 group, dose-2 group - Gout Arthritis | Phase 1 | Completed | Innovent Biologics (Suzhou) Co. Ltd. | 30 | 2024-03-05 | 2024-03-22 |
| NLRP3 Inflammasome Activation Among Patients During Acute Gout Flares Gout Arthritis | Unknown | Centre Hospitalier Saint Joseph Saint Luc de Lyon | 10 | 2023-04-28 | 2023-05-12 | |
| Evaluation and Characterisation of Microplastics and Nanoplastics in Joint Synovial Liquid Synovial fluid analysis - Osteoarthritis, Knee, Knee Arthritis | Unknown | Iuliu Hatieganu University of Medicine and Pharmacy | 50 | 2023-01-15 | 2023-01-10 | |
| The Relationship Between Cold Water Immersion and the Progression in Gout Arthritis Cold Water Immersion - Gout Arthritis | Not applicable | Completed | Taipei Medical University | 76 | 2019-07-01 | 2021-03-17 |
Arthritis, Gouty (13) · Gout (2) · Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (1) · Arthritis, Psoriatic (1) · Arthritis, Rheumatoid (1) · Connective Tissue Diseases (1) · Diabetes Mellitus (1) · Dyslipidemias (1) · Elephantiasis (1) · Giant Cell Arteritis (1) · Hypertension (1) · Hyperuricemia (1) · Motor Activity (1) · Myositis (1) · Osteoarthritis, Knee (1)
Arthritis (13) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (13) · Crystal Arthropathies (13) · Genetic Diseases, Inborn (13) · Joint Diseases (13) · Metabolic Diseases (13) · Metabolism, Inborn Errors (13) · Musculoskeletal Diseases (13) · Nutritional and Metabolic Diseases (13) · Purine-Pyrimidine Metabolism, Inborn Errors (13) · Rheumatic Diseases (12) · Gout (11) · Cardiovascular Diseases (2) · Immune System Diseases (2) · Pathological Conditions, Signs and Symptoms (2)
Colchicine (2) · Allopurinol (1) · Betamethasone (1) · Etoricoxib (1) · Febuxostat (1) · Jogging (1)
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. (2) · Centre Hospitalier Saint Joseph Saint Luc de Lyon (1) · Chang Gung University of Science and Technology (1) · Haiphong University of Medicine and Pharmacy (1) · Innovent Biologics (Suzhou) Co. Ltd. (1) · Iuliu Hatieganu University of Medicine and Pharmacy (1) · Laboratorios Silanes S.A. de C.V. (1) · Massachusetts General Hospital (1) · Taipei Medical University (1) · University of Aarhus (1) · University of Bonn (1) · Zhu Xiaoxia (1)
China (2) · Denmark (1) · France (1) · Germany (1) · Indonesia (1) · Mexico (1) · Taiwan (1) · United States (1)
Hejian Zou, MD (1) · Hsiu Ting Tsai, PhD (1) · Hyon K Choi, MD, DrPH (1) · Qinghong Zhou (1) · Rafael Lanuza-Ramirez, MD (1) · Rodrigo Suarez-Otero, MD (1)